It may be that the share-price of Sirtex is entering a broad trading between $19 and $29 after the dramatic fall from grace on the 17th March 2015 to $14.80 from $40. There have been two higher highs since then… Read More ›
colorectal cancer
CHART REVIEW – UPDATE ON SIRTEX.
This blog reviewed the ASX listed stock Sirtex (SRX) on the 15/1/2014. https://technicality.me/2014/01/15/sirtex-succeeds/ At that time this stock was in full flight, propelled by strong momentum that appeared at that time to be starting to falter. A dramatic fall from… Read More ›
Technically Speaking 